Skip to main content
. 2012 May 6;12:168. doi: 10.1186/1471-2407-12-168

Table 5.

Cancer mortality in Aboriginal females, NSW, 1999-2007, and risk comparison with non-Aboriginal females

    Mortality rate1 per 100,000 (95% CI)   Risk3 to age 75, 1 in:  
Cancer site
Deaths
 
SMR2 (95% CI)
Aboriginal
Non-Aboriginal
Head and neck
18
6.8 (3.8-11.1)
3.21 (1.90-5.07)
135
608
Oesophagus
11
4.5 (2.0-8.5)
2.40 (1.20-4.29)
316
787
Stomach
17
7.9 (4.2-13.2)
1.98 (1.15-3.16)
235
433
Large bowel
49
23.6 (16.7-32.2)
1.24 (0.92-1.64)
81
87
Liver
10
4.6 (2.0-8.9)
2.19 (1.05-4.03)
260
768
Pancreas
29
15.0 (9.6-22.2)
1.82 (1.22-2.61)
118
201
Lung
134
57.8 (47.4-69.6)
2.73 (2.29-3.23)
25
62
Melanoma of skin
9
4.1 (1.6-8.2)
1.00 (0.46-1.89)
325
442
Breast
99
35.6 (28.0-44.4)
1.54 (1.25-1.88)
37
59
Cervix
31
10.9 (6.8-16.2)
4.74 (3.22-6.73)
123
663
Uterus
13
6.4 (3.1-11.5)
2.05 (1.09-3.51)
259
490
Ovary
22
8.3 (4.8-13.1)
1.35 (0.84-2.04)
157
203
Kidney
16
6.9 (3.6-11.7)
2.36 (1.35-3.82)
188
469
Brain
15
5.5 (2.7-9.7)
1.20 (0.67-1.98)
208
315
Non-Hodgkin’s lymphoma
13
5.3 (2.5-9.6)
1.00 (0.53-1.72)
213
277
All leukaemias
15
5.4 (2.5-9.6)
1.17 (0.66-1.94)
389
345
Unknown primary
35
14.4 (9.4-20.8)
1.35 (0.94-1.88)
103
138
All cancers 572 240.3 (218.5-263.5) 1.73 (1.59-1.88) 6.5 11.1

1Directly age-standardised to 2001 Australian census population.

2Standardised mortality ratio in relation to all NSW females.

3Cumulative risk.